Forever stocks |మన మార్కెట్స్ లో ఇక పండగే పండగ| A new bull market has just started#Seshu Amperayani

Finance-focused summary of the subtitles

Macro / markets view (India)

• Nifty level: Currently above 24,200.
• Geopolitics: “Bad news” on the geopolitical side caused the index to fall, but it rebounded afterward.
• Negative news largely over: The speaker claims most negative India-market news is already priced in / over.
• Crude oil: Mentioned around 70 (units implied as $/barrel or similar). The speaker expects crude to stay around 70 after a recent rise.

• Monsoon:

  • Early days: about ~ -50% deficit
  • Later improved: about -14% deficit Described as supportive for India’s economy.

• Fund flows (first 5 months of 2026):

  • Domestic mutual funds: bought ~₹4.16 lakh crore
  • FIIs: sold ~₹2.8 lakh crore (stated as ~2.77 to 2.80 lakh crore)
• Conclusion / reasoning: Despite FIIs selling, the market remains “strong” because domestic buyers and liquidity/retail participation can offset it; also implies limited further selling pressure.

Strategy / investment stance

• Theme: A bull phase may be starting, supported by festivals. The speaker also cites “Trump-related news” as ongoing uncertainty but expects markets to generally move into bull mode.
• Approach: Prefer stock selection over index strength, since index constituents are described as “not particularly strong.”
• Forward-looking recommendation (explicit):
  • Expect inflows to restart within 2–3 months
  • Improve odds of a bull market into year-end

---

Stock ideas (key numbers + valuation/risk commentary)

1) Ashoka Buildcon (infrastructure: highways / bridges)

• Target price range mentioned (historical/view): 160–170–180
  • Speaker earlier referenced “mid-80s,” later calling it high again; the stock then fell.
• Why infra performed weakly despite sector strength:
  • Receivables delay over the past two years
  • Government spending not aggressive: last budget allocation described as same as last year
  • Cost / margin sensitivity:
    • If cement/steel rates rise → input costs up → margins down
    • Bank interest rises with leverage/debt
• Debt / deleveraging (timelines/levels mentioned):
  • ~1.5 years back: debt described as lower
  • Later: debt increased to ~₹5,000 crores
  • Subsequently reduced to about ₹1,600 crores
  • BOT projects sold recently to reduce debt; ~₹1,800 crores came from the sale
• Growth deterioration (major reason cited):
  • FY25 top line: ~₹10,000 crores
  • FY26 referenced: ~₹7,500 crores
  • Implied decline: ~25–26% top-line growth decrease
• Bullish offsets / catalysts:
  • Order book up ~15%
  • “Recently received orders”
  • Valuations described as attractive
  • Speaker’s stance: despite delays, long-term model remains; for long-term, “you should hold” and “bouncing chances are increasing.”
• Recommendation style: Hold for long term, expecting recovery as receivables and order flow stabilize.

2) KMC Specialty Hospital (healthcare “sustaining” model example)

• Used as an example of a stock that corrected then rerated.
• Benchmarks / claims:
  • Beds: described as 300-bed (also mentions 225–250-bed variants)
  • Market cap / valuation references: subtitles appear inconsistent/contradictory:
    • “Market cap… 2200 crores”
    • Later references conflicting figures (e.g., 300 crores vs turnover/revenue references around 10,000 crores)
• Valuation argument about PE:
  • If the stock has “high P” (price), why is PE 35?
  • Reply: as results normalize in 1–3 quarters, PE should decrease automatically (earnings improve / denominator effect).

---

Healthcare sector thesis (framing for “sunrise sectors”)

• Demand driver: India needs a few lakh beds over the next 20–30 years.
• Private vs government: Speaker claims ~85% of healthcare in India is in private hands, implying opportunity to transition from unorganized to organized.
• Expected consolidation: Small hospitals may close; growth shifts to branded/organized players.
• Company examples named: Apollo, KIMS, Narayana Hrudayala, Max
  • Mentions possible unlisted example: Yashoda
• Medical tourism: Speaker claims it will be a major income source for India over the next 5–6 years.

Apollo Hospital performance example (very explicit)

• ~8,800 mentioned (likely a numeric metric; subtitles unclear).
• Market cap: around ₹26,000 crores
• 20-years-ago price: ₹200
• Current example price range claim: moved from 8000 to 9000
• Growth estimate: ~4,320% over 20 years
• Implied return: speaker suggests roughly ~200% per year (calculation claim)
• Upside tone: subtitles mention “it could go to 4000” (context unclear whether price or another metric)

---

Event / community disclosure (non-finance metrics)

• Investor meeting: Vijayawada on July 26
• Attendance cap: only 20 people registered in advance (speaker contrasts with prior 300–400 attendees)
• Focus: healthcare sector business models, identify ~20 interesting companies, and 25–30 minutes of interaction per participant

---

“Crizel Rating Agency” / valuation-advisory thesis (meta-investing idea)

• Mentions Crizel rating agency (Research Rating and Advisory):
  • New businesses need research
  • Research involves analyzing economy/industry with data (e.g., monsoon impacts growth; sales volumes like lakhs of cars/bikes)
  • Their revenue is primarily from research
  • Claims valuation is “not expensive” and suggests buying such companies
  • Strong claim: even if it fails, “buy with confidence and keep advertising” (subtitles do not include standard risk disclaimers)
• Lending angle: Mentions credit/debt and bank loan eligibility based on ratings

---

Instruments / tickers / companies explicitly mentioned

• Index: Nifty (level ~ 24,200)
• Oil: Crude (~70)
• Companies / sectors:
  • Ashoka Buildcon
  • KMC Specialty Hospital
  • Apollo Hospitals (also “Apollo”)
  • KIMS, Narayana Hrudayala, Max
  • Yashoda (unlisted mention)
  • Crizel (research/rating/advisory firm)
• No explicit ETF/bond/crypto tickers provided.

---

Methodology / framework explicitly shared (repeatable logic)

• Macro-to-portfolio (implied):
  1. Check macro headwinds (geopolitics, crude, monsoon)
  2. Track fund flows (domestic mutual funds vs FIIs)
  3. Conclude whether selling pressure is limited and domestic liquidity can support markets
  4. Prefer stock selection over index selection
• Stock evaluation logic (for infra example, implied checklist):
  • Assess receivables/debt trends
  • Evaluate top-line growth deterioration/improvement
  • Check order book growth
  • Consider valuation attractiveness
  • Monitor cost/margin sensitivity (cement/steel input costs, interest rates)

---

Key numbers & timelines (quick list)

• Nifty: > 24,200
• Crude oil: around 70; expected to stay near 70
• Monsoon deficit: early ~ -50% → later ~ -14%
• Fund flows (first 5 months of 2026):
  • Domestic mutual funds: ~₹4.16 lakh crore bought
  • FIIs: ~₹2.8 lakh crore sold
• Inflows expectation: restart in 2–3 months
• Year-end bull market expectation: through festivals → year-end
• Ashoka Buildcon:
  • Debt peak: ~₹5,000 crores
  • Debt later: ~₹1,600 crores
  • BOT sale cash: ~₹1,800 crores
  • Revenue/top-line: ₹10,000 crores → ₹7,500 crores (~25–26% decline)
  • Order book growth: ~15%
  • Target price range cited: 160–170–180
• Healthcare thesis horizons:
  • Bed requirement: next 20–30 years
  • Medical tourism income: next 5–6 years
• Investor meeting: July 26; only 20 registrants; 25–30 min per participant
• PE rationale timing: earnings normalize in 1–3 quarters

---

Disclosures / disclaimers

• The subtitles include no clear “not financial advice” disclaimer.

---

Presenter / sources (as named)

• Andy (greeting: “Hello Andy… welcome to Profit Master.”)
• Seshu Amperayani (appears in the video title)